COVID - 19


Mayo Clinic’s Patient-First Pandemic Response
Watch the Virtual Event
Hero photo

Through expertise, innovation and a commitment to its patient-first values, Mayo Clinic plays a leading role in the worldwide pandemic response.

This virtual event was recorded on Thursday, March 11, 2021.

Meet the Speakers

Dr. Galanis is a consultant in the Department of Oncology with a joint appointment in the Department of Molecular Medicine at Mayo Clinic in Rochester, Minnesota. She serves as executive dean of Development. Dr. Galanis is an accomplished oncologist and virology researcher who has expanded the field of virotherapies for cancer. Dr. Galanis holds a named position as the Sandra J. Schulze Professor.

A patient-focused vision for the future

Early in 2020, Mayo Clinic was focused on a set of priorities and initiatives that would revolutionize health care in the next 10 years. As the COVID-19 pandemic emerged, Mayo Clinic moved to implement its most important initiatives that would allow clinicians, researchers and educators to adapt quickly, respond efficiently and provide the care our patients and patients everywhere needed.

Beyond COVID-19

The nationwide response to COVID-19, including vaccine distribution, is a highly complex undertaking, and we understand you are as eager as we are to put this pandemic in the past. Mayo Clinic is continuing to coordinate with state and local governments on future vaccine distribution phases.

The latest information and resources available to patients can be found at Mayo Clinic’s COVID-19 information hub.

This event will share Mayo Clinic’s patient-focused innovations in the past year and what will come next. Because of the complexity of COVID-19 responses and vaccination plans, our speakers will not address questions that are specific to geographies or individual patient scenarios.

Novel Therapies

Patients with COVID-19 who received Mayo Clinic care had outcomes that compared favorably to those reported nationally and internationally.

Advanced Diagnostics

Mayo Clinic Laboratories developed 14 new diagnostic and antibody tests and has performed more than 3.1 million COVID-19 tests in the U.S.

Innovative Approaches

Mayo Clinic led the U.S. Expanded Access Program for convalescent plasma to treat critically ill COVID-19 patients.

Care at Home

Mayo Clinic initiated the advanced care at home program to allow patients to recover safely in their own homes from a variety of conditions, including COVID-19.